Zhende Medical Co Ltd Tangible Net Worth Ratio
Zhende Medical Co Ltd tangible net worth ratio. Zhende Medical Co Ltd (603301) has a Tangible Net Worth Ratio of 87.8% as of June 2026. This metric is calculated by deducting intangible assets (CN¥721.97 Million) from net assets (CN¥5.94 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Zhende Medical Co Ltd to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Zhende Medical Co Ltd (2014–2025)
Tangible net worth ratio of Zhende Medical Co Ltd from 2014 to 2025. This chart shows how Zhende Medical Co Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 87.8%, reflecting net assets of CN¥5.94 Billion with intangible assets of CN¥721.97 Million CNY. Check Zhende Medical Co Ltd (603301) strategic investment index to assess the company's strategic physical and investment asset allocation.
Zhende Medical Co Ltd Tangible Net Worth Ratio by Year (2014–2025)
Zhende Medical Co Ltd tangible net worth ratio by year from 2014 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Zhende Medical Co Ltd from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 603301 market cap.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.6% | CN¥5.96 Billion | CN¥737.31 Million | CN¥8.40 Billion | ▼ -0.2 pp |
| 2024 | 87.8% | CN¥5.90 Billion | CN¥718.08 Million | CN¥7.58 Billion | ▼ -1.3 pp |
| 2023 | 89.2% | CN¥5.60 Billion | CN¥607.10 Million | CN¥7.27 Billion | ▼ -1.0 pp |
| 2022 | 90.2% | CN¥5.76 Billion | CN¥564.46 Million | CN¥7.90 Billion | ▲ +0.2 pp |
| 2021 | 90.0% | CN¥4.44 Billion | CN¥444.82 Million | CN¥6.42 Billion | ▼ -5.0 pp |
| 2020 | 94.9% | CN¥4.47 Billion | CN¥225.62 Million | CN¥6.40 Billion | ▲ +8.2 pp |
| 2019 | 86.8% | CN¥1.40 Billion | CN¥185.13 Million | CN¥2.67 Billion | ▼ -1.5 pp |
| 2018 | 88.2% | CN¥1.12 Billion | CN¥132.40 Million | CN¥1.85 Billion | ▲ +5.2 pp |
| 2017 | 83.1% | CN¥560.19 Million | CN¥94.84 Million | CN¥1.29 Billion | ▲ +5.3 pp |
| 2016 | 77.8% | CN¥438.18 Million | CN¥97.27 Million | CN¥1.13 Billion | ▲ +13.8 pp |
| 2015 | 64.0% | CN¥262.45 Million | CN¥94.37 Million | CN¥1.27 Billion | ▲ +33.5 pp |
| 2014 | 30.5% | CN¥105.77 Million | CN¥73.52 Million | CN¥1.11 Billion | — |